Omega Healthcare Investors (OHI) Stock Overview
A real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 6/6 |
OHI Community Fair Values
Create NarrativeSee what 74 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Omega Healthcare Investors, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$47.95 |
| 52 Week High | US$50.10 |
| 52 Week Low | US$37.58 |
| Beta | 0.57 |
| 1 Month Change | 6.06% |
| 3 Month Change | 2.94% |
| 1 Year Change | 26.25% |
| 3 Year Change | 46.73% |
| 5 Year Change | 28.07% |
| Change since IPO | 128.33% |
Recent News & Updates
Narrative Update • Jun 18
OHI: Leadership Succession And Improving Tenant Credit Are Expected To Drive Upside
The analyst price target for Omega Healthcare Investors has been adjusted slightly from $51.00 to about $50.82, reflecting updated views on tenant credit quality, external growth prospects, and recent revisions to broader REIT models across the Street. Analyst Commentary Recent research on Omega Healthcare Investors presents a mixed picture, with several firms adjusting price targets and ratings as they refresh REIT models, update assumptions around tenant credit quality, and factor in interest rate impacts.Seeking Alpha • Jun 17
Omega Healthcare: Still A Great Company, But No Longer The Bargain It Was
Summary Omega Healthcare Investors is downgraded from bullish to neutral as valuation now reflects its recovery and growth prospects. OHI’s dividend is well covered, with payout ratios at 82% of AFFO and 86% of FAD, and management hints at a possible raise in 2027. Active portfolio management, capital recycling, and a strategic pivot toward RIDEA and senior housing are driving operational improvements and future growth potential. Key risks include execution on new operating structures, leadership transition, compressed yields, and macro headwinds from potential interest rate hikes. Read the full article on Seeking AlphaRecent updates
Narrative Update • Jun 18
OHI: Leadership Succession And Improving Tenant Credit Are Expected To Drive Upside
The analyst price target for Omega Healthcare Investors has been adjusted slightly from $51.00 to about $50.82, reflecting updated views on tenant credit quality, external growth prospects, and recent revisions to broader REIT models across the Street. Analyst Commentary Recent research on Omega Healthcare Investors presents a mixed picture, with several firms adjusting price targets and ratings as they refresh REIT models, update assumptions around tenant credit quality, and factor in interest rate impacts.Seeking Alpha • Jun 17
Omega Healthcare: Still A Great Company, But No Longer The Bargain It Was
Summary Omega Healthcare Investors is downgraded from bullish to neutral as valuation now reflects its recovery and growth prospects. OHI’s dividend is well covered, with payout ratios at 82% of AFFO and 86% of FAD, and management hints at a possible raise in 2027. Active portfolio management, capital recycling, and a strategic pivot toward RIDEA and senior housing are driving operational improvements and future growth potential. Key risks include execution on new operating structures, leadership transition, compressed yields, and macro headwinds from potential interest rate hikes. Read the full article on Seeking AlphaNarrative Update • Jun 03
OHI: Senior Housing Expansion And 2026 Leadership Succession Plan Will Support Upside Potential
Analysts have increased their average price target for Omega Healthcare Investors by $0.88 to $51.00, reflecting a series of incremental target adjustments across the Street while keeping assumptions such as discount rates and profit margins broadly in line with prior models. Analyst Commentary Recent research updates present a mixed but generally constructive view on Omega Healthcare Investors, with several firms adjusting price targets higher while keeping a range of ratings from Underperform to Buy.Narrative Update • May 17
OHI: Senior Housing Expansion And External Deals Will Guide Balanced 2026 Outlook
Narrative Update on Omega Healthcare Investors The analyst price target for Omega Healthcare Investors has been revised higher by $0.75 to $50.13. This reflects a series of recent target increases from multiple firms as analysts highlight updated sector views and company specific factors.Narrative Update • Apr 25
OHI: Senior Housing Expansion And External Deals Will Shape Balanced 2026 Outlook
Analysts now see fair value for Omega Healthcare Investors edging down by $0.25 to $49.38. This reflects a mix of recent price target increases from several firms and fresh downgrades that highlight both improved revenue assumptions and some caution around margins and valuation.Narrative Update • Apr 10
OHI: Senior Housing Shift And External Growth Will Shape 2026 Outlook
The analyst price target for Omega Healthcare Investors edges higher to $49.63, as analysts factor in updated fair value estimates, a slightly higher discount rate, and adjustments to revenue growth, profit margin, and future P/E assumptions following a series of recent target raises across the Street. Analyst Commentary Recent Street research on Omega Healthcare Investors reflects a mix of optimism around the current setup and caution about relative opportunities across healthcare REITs. Price targets have been reset to reflect updated fair value work, with views split between those who see room for further execution upside and those who see the shares as closer to fully valued.Narrative Update • Mar 26
OHI: Senior Housing NNN Shift And 2026 Outlook Will Shape Balanced Setup
The analyst price target for Omega Healthcare Investors edges higher to $49.50, with analysts highlighting gradual model tweaks tied to senior housing growth opportunities and updated views on the REIT sector. Analyst Commentary Recent research on Omega Healthcare Investors shows a mix of optimism around senior housing growth and caution on how much upside is left at current levels.Narrative Update • Mar 11
OHI: Senior Housing NNN Shift And 2026 Outlook Will Guide Fairly Balanced Setup
Omega Healthcare Investors' analyst price target has moved modestly higher to $49.25 from $48.88 as analysts factor in updated fair value estimates, slightly lower discount rates, and a more constructive view on senior housing growth compared with other healthcare REIT options. Analyst Commentary Recent research updates on Omega Healthcare Investors highlight a mix of optimism around senior housing growth and portfolio repositioning, alongside caution on valuation and medium term guidance.Narrative Update • Feb 25
OHI: Senior Housing NNN Shift And 2026 REIT Turnaround Will Shape Balanced Outlook
Our analyst price target for Omega Healthcare Investors edges up by about $0.80 to $48.88. This reflects a blend of higher Street targets and expectations from analysts for steadier cash flows, even as views on revenue growth and margins become more cautious.Narrative Update • Feb 10
OHI: Senior Housing NNN Shift And 2026 REIT Turnaround Will Guide Balanced Outlook
The analyst price target for Omega Healthcare Investors has moved up by about $1, to roughly $48, as analysts weigh a slightly lower discount rate, a modestly higher profit margin expectation, and recent Street research that includes multiple target hikes alongside a few valuation-driven downgrades. Analyst Commentary Recent Street research on Omega Healthcare Investors shows a mix of optimism and caution, with several firms adjusting price targets and ratings as they reassess the risk and return trade off.Narrative Update • Jan 26
OHI: Future Senior Housing NNN Expansion And REIT Turnaround Will Shape Measured Upside
Analysts have nudged our fair value estimate for Omega Healthcare Investors higher to US$47.13 from US$46.47, reflecting updated assumptions around revenue growth, profitability and future P/E in light of a series of recent price target moves and mixed, but generally constructive, research commentary on senior housing and NNN-focused REITs. Analyst Commentary Recent Street research on Omega Healthcare Investors presents a mix of optimism and caution, with price targets clustered in the mid US$40s to low US$50s and a range of ratings from Buy to Neutral and Market Perform. Taken together, the commentary helps frame how different investors are thinking about growth, capital deployment, and execution risk in senior housing and NNN-focused REITs. Bullish Takeaways Bullish analysts highlight potential upside in senior housing occupancy, revenue per occupied room and margins, which they see as supportive of higher earnings power relative to current expectations.Narrative Update • Jan 08
OHI: Future Investment Activity And Sector Turnaround Expectations Will Shape Measured Upside Potential
Narrative Update The analyst price target for Omega Healthcare Investors has edged higher in recent research, with several firms lifting targets into the mid US$40s to low US$50s range. Analysts are highlighting a potential broader U.S. REIT turnaround, improving investment volumes and solid EBITDAR coverage.Narrative Update • Dec 14
OHI: Future Investment Activity And Dividend Consistency Will Drive Measured Upside Potential
The analyst price target for Omega Healthcare Investors has been raised modestly from approximately $45.94 to $46.56 per share, as analysts cite stronger expected investment volumes, a broad addressable market, and resilient REIT earnings as support for higher long term revenue growth and margins. Analyst Commentary Recent Street research reflects a generally constructive view on Omega Healthcare Investors, with multiple firms lifting price targets into the mid to high $40s and several anchoring on upside scenarios that reach $50 per share.Narrative Update • Nov 28
OHI: Future Investment Activity And Dividend Consistency Will Shape Sector Resilience
Omega Healthcare Investors' analyst price target has risen modestly from $45.13 to $45.94 per share, as analysts cite stronger investment volumes, a broad addressable market, and continued earnings resilience as key factors behind the upward revision. Analyst Commentary Recent analyst research has provided a mix of optimism and caution regarding Omega Healthcare Investors.Narrative Update • Nov 14
OHI: Future Margin Gains And Dividend Stability Will Support Sector Positioning
Omega Healthcare Investors' consensus fair value estimate has increased by $1.00 to $45.13, as analysts cite recent price target revisions and improvements in profit margin outlook as key supporting factors. Analyst Commentary Recent street research has pointed to multiple price target increases for Omega Healthcare Investors, supported by a constructive outlook on earnings growth, dividend coverage, and sector positioning within the REIT universe.Narrative Update • Oct 31
OHI: Future Dividend Coverage And Sector Resilience Will Support Balanced Outlook
Omega Healthcare Investors' analyst price target has increased slightly, rising to $44.13 from $44.07. Analysts cite improved dividend coverage prospects and positive sector performance as key supporting factors.Narrative Update • Oct 17
US And UK Senior Care Demand Will Sustain Future Expansion
Omega Healthcare Investors' analyst price target has increased slightly, rising by $0.20 to $44.07 per share. Analysts cite improved dividend coverage prospects and continued solid performance in the senior housing REIT sector as reasons for this adjustment.Narrative Update • Oct 03
US And UK Senior Care Demand Will Sustain Future Expansion
Omega Healthcare Investors’ analyst price target has increased from $43.21 to $43.87 per share. This change reflects analysts’ view that the company’s strengthened revenue outlook and improving sector sentiment warrant a modest upward revision.Narrative Update • Aug 31
US And UK Senior Care Demand Will Sustain Future Expansion
Omega Healthcare Investors’ price target was raised to $42.57 as analysts cite resilient rental collections despite regulatory and tenant headwinds, a robust acquisition pipeline, and stable property fundamentals, driving improved risk-reward sentiment. Analyst Commentary Price target increases reflect updated Q2 sector results and overall REIT valuation adjustments.Seeking Alpha • Mar 14
Omega Healthcare: The Pullback Is An Opportunity As The Risk-Free Rate Of Return Declines
Summary Omega Healthcare Investors rebounded in 2024, surpassing $1 billion in annual revenue and investing $1.1 billion in new properties and loans. Despite a recent 15% decline, OHI's valuation remains attractive, with strong revenue, EBITDA growth, and a high dividend yield of 7.29%. Risks include dependency on Medicare/Medicaid policies, interest rate hikes, and $4.44 billion in long-term debt, potentially impacting profitability and dividend coverage. OHI's triple net lease structure and strategic investments position it well for future growth, making it a compelling long-term investment opportunity. Read the full article on Seeking AlphaSeeking Alpha • Jan 08
Omega Healthcare Investors: Covered Dividend And Transformation Make It A Buy
Summary Omega Healthcare Investors is a leading triple-net lease REIT specializing in skilled nursing facilities, offering a 7.2% yield supported by improving fundamentals. OHI has shown resilience, evidenced by strong Q3 results, revenue growth, and a fully covered dividend, making it an attractive buy. Strategic investments in senior housing and operator recoveries position OHI to capitalize on growing demand from an aging population. Trading at a forward P/FFO of 13.2, OHI offers a balanced mix of income and growth potential for dividend investors. Read the full article on Seeking AlphaSeeking Alpha • Nov 29
Omega Healthcare Investors: Patience Is Seemingly Paying Off
Summary Omega Healthcare Investors has shown significant improvements, with FFO and revenue beating estimates, and strong growth in tenant payments and new investments in 2024. The REIT's payout ratio has decreased but remains high at 96%; management expects it to fall below 90% in upcoming quarters. OHI's valuation has increased, with a forward P/AFFO multiple of 14.07x, still below the sector median, offering potential upside. Despite improvements, higher interest rates and future debt maturities pose risks; I maintain a hold rating until the payout ratio further decreases. Uncertainty surrounding interest rates still present risks as well as their elevated payout ratio, giving the REIT little margin for error. Read the full article on Seeking AlphaSeeking Alpha • Oct 05
Omega Healthcare Investors: Not An Alpha Generating Stock
Summary Omega Healthcare Investors Inc. is a healthcare REIT focused on skilled nursing and assisted living triple-net leases. The company has been overleveraged in favor of short-term growth, crippling medium and long-term growth. Additional risks include considerable opportunity costs, as a near or medium-term return to dividend growth is unlikely. I, therefore, rate OHI a "Sell" and encourage most investors to look for new opportunities. Read the full article on Seeking AlphaSeeking Alpha • Sep 12
Omega Healthcare Investors: High Dividend Yield And An Expected Massive Market
Summary OHI has strong financials, superior profit-making efficiency, and a high dividend yield of 6.65%. It is particularly well-placed in a niche market that will have high-growth product of a deep demographic shift while surrounded. All of this, while surrounded by a regulatory moat, makes it an ideal stock for enjoying both income and high-growth potential. Read the full article on Seeking Alpha
New Narrative • Aug 25
Critical Acquisitions And Market Expansion Fuel Revenue Growth Despite Analysts' Conservative Forecasts
Strategic growth and operational improvements among tenants are expected to increase overall portfolio stability and enhance earnings through reliable rent collections.Seeking Alpha • Aug 05
Omega Healthcare: Attractive 7% Yield + 3 Other High Yield REITs
Summary Omega Healthcare is a healthcare real estate company with a 7% yield, is compared to peers Sabra, LTC, and Ventas using FFO, yield and more. Omega operates in 42 states and the UK, with a market cap of $10 billion and a BBB- S&P credit rating. Omega has maintained a steady dividend for 20 years, with recent FFO earnings showing positive growth trends. The Rose Take and Recommendation is given for owning Omega. Read the full article on Seeking AlphaSeeking Alpha • Jun 14
Omega Healthcare Investors: 8.4% Yield And Selling Below Fair Price
Summary Omega Healthcare Investors covered its dividend with adjusted funds from operations in 1Q24, with an improved margin of safety. The trust completed $75 million in new investments in 1Q24 and continues to divest underperforming assets, maintaining a moderate risk/reward relationship. Omega Healthcare Investors anticipates earning $2.70 - $2.80 per share in adjusted funds from operations in 2024, selling for a 11.6x AFFO multiple. Read the full article on Seeking AlphaSeeking Alpha • Jun 03
Omega Healthcare: You May Want To Wait For A Better Price
Summary Omega Healthcare Investors has a diversified portfolio of skilled nursing and assisted living facilities, but significant exposure to a few operators. Moreover, the price performance of OHI has been underwhelming, and the company has had issues with collecting rent from tenants. More importantly, the dividend is not safe and the discount to NAV is not large enough to provide an adequate margin of safety here. Read the full article on Seeking AlphaSeeking Alpha • May 21
Omega Healthcare: Clarity Regarding The Dividend Makes This 8.75% REIT Interesting
Summary Omega Healthcare Investors focuses on long-term care and skilled nursing facilities, which are expected to see increased demand as the US population ages. OHI's dividend has been the subject of debate, but management projects that the large yield is secure and will continue at $2.68 per share annually. OHI's Q1 2024 results showed growth in revenue, net income, and funds from operations, indicating strong performance and execution by senior leadership. Read the full article on Seeking AlphaShareholder Returns
| OHI | US Health Care REITs | US Market | |
|---|---|---|---|
| 7D | -2.9% | -1.1% | 0.2% |
| 1Y | 26.3% | 36.9% | 19.6% |
Return vs Industry: OHI underperformed the US Health Care REITs industry which returned 36.9% over the past year.
Return vs Market: OHI exceeded the US Market which returned 19.6% over the past year.
Price Volatility
| OHI volatility | |
|---|---|
| OHI Average Weekly Movement | 3.2% |
| Health Care REITs Industry Average Movement | 4.0% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: OHI has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: OHI's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 69 | C. Pickett | www.omegahealthcare.com |
Omega Healthcare Investors, Inc. is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK and Canada.
Omega Healthcare Investors, Inc. Fundamentals Summary
| OHI fundamental statistics | |
|---|---|
| Market cap | US$15.06b |
| Earnings (TTM) | US$615.87m |
| Revenue (TTM) | US$1.23b |
23.2x
P/E Ratio11.6x
P/S RatioIs OHI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OHI income statement (TTM) | |
|---|---|
| Revenue | US$1.23b |
| Cost of Revenue | US$8.66m |
| Gross Profit | US$1.22b |
| Other Expenses | US$605.08m |
| Earnings | US$615.87m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Jul 29, 2026
| Earnings per share (EPS) | 2.07 |
| Gross Margin | 99.30% |
| Net Profit Margin | 50.09% |
| Debt/Equity Ratio | 81.5% |
How did OHI perform over the long term?
See historical performance and comparisonDividends
5.6%
Current Dividend Yield82%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/15 21:32 |
| End of Day Share Price | 2026/07/15 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Omega Healthcare Investors, Inc. is covered by 34 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Rodgers | Baird |
| Amanda Sweitzer | Baird |
| Richard Hightower | Barclays |